Novel approach to in vitro drug susceptibility assessment of clinical strains of Leishmania spp
about
Strategies to overcome antileishmanial drugs unresponsivenessMiltefosine and antimonial drug susceptibility of Leishmania Viannia species and populations in regions of high transmission in ColombiaEx vivo host and parasite response to antileishmanial drugs and immunomodulatorsLeishmania panamensis infection and antimonial drugs modulate expression of macrophage drug transporters and metabolizing enzymes: impact on intracellular parasite survival.Treatment failure and miltefosine susceptibility in dermal leishmaniasis caused by Leishmania subgenus Viannia species.Pharmacokinetics of Miltefosine in Children and Adults with Cutaneous Leishmaniasis.Comparison of a high-throughput high-content intracellular Leishmania donovani assay with an axenic amastigote assay.Evaluating drug resistance in visceral leishmaniasis: the challenges.Susceptibility Testing of Medically Important Parasites.Lack of correlation between the promastigote back-transformation assay and miltefosine treatment outcome.Detection and identification of Leishmania spp.: application of two hsp70-based PCR-RFLP protocols to clinical samples from the New World.Profiling gene expression of antimony response genes in Leishmania (Viannia) panamensis and infected macrophages and its relationship with drug susceptibility.What steps can be taken to counter the increasing failure of miltefosine to treat visceral leishmaniasis?Intraspecies differences in natural susceptibility to amphotericine B of clinical isolates of Leishmania subgenus Viannia.
P2860
Q26849297-1F4FEB92-352E-4075-86AD-C9743E19D926Q28539068-FD275936-ED6C-4970-BCBA-9D062AA13FBAQ28547648-B0FE3D8B-1658-40AC-B76E-A61AAD145A16Q37388291-0D3DA865-7D26-49AE-8420-2CD4EE454B05Q37544280-4F2A120A-9161-42CC-9073-4B8B94BEB93BQ37669845-1A17E172-2E8F-40AE-A4D0-4E308D647A53Q38966911-B7E6C5A0-54E3-4E90-B80C-482566791AC4Q39014583-3888B105-A423-4441-8483-E6F99534C1A8Q39020376-023B45AB-C363-4732-90C6-AC1D40D3FA5EQ39063747-FED2D3EF-AE5D-498A-A34D-96D1AA2F903DQ39263491-B20DA776-CD87-4A80-B1C2-56E84CDA55B5Q40078925-025208FE-87A1-48C3-9D74-8AF15451F993Q44920807-82058EB5-F801-4AE9-BFBF-945680C01E19Q55210168-92B1E51D-BB43-4FD5-A1B9-0DD7A386A219
P2860
Novel approach to in vitro drug susceptibility assessment of clinical strains of Leishmania spp
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Novel approach to in vitro dru ...... ical strains of Leishmania spp
@ast
Novel approach to in vitro dru ...... ical strains of Leishmania spp
@en
type
label
Novel approach to in vitro dru ...... ical strains of Leishmania spp
@ast
Novel approach to in vitro dru ...... ical strains of Leishmania spp
@en
prefLabel
Novel approach to in vitro dru ...... ical strains of Leishmania spp
@ast
Novel approach to in vitro dru ...... ical strains of Leishmania spp
@en
P2093
P2860
P356
P1476
Novel approach to in vitro dru ...... ical strains of Leishmania spp
@en
P2093
Clemencia Ovalle
Harry Castillo
Liliana Valderrama
Mabel Valderrama
Mauricio Perez
Nancy Gore Saravia
Olga Fernández
Yira Diaz-Toro
P2860
P304
P356
10.1128/JCM.00216-12
P407
P577
2012-04-18T00:00:00Z